News Bidding war breaks out as Novo raises Metsera bid to $10bn Metsera has now received new takeover bids from both Pfizer and Novo Nordisk, and has plumped for a sweetened $10bn offer from the latter.
News Pfizer files another lawsuit against Metsera, Novo Nordisk Metsera says Novo Nordisk's takeover offer is superior to one filed by Pfizer, and the latter files a new lawsuit to try to force their deal through.
News Free Wegovy trialled in deprived areas of Scotland Thousands of people from Scotland's most deprived areas will get free weight-loss jabs in a real-world study to gauge if they can save the NHS money.
News Pfizer sues to block Novo Nordisk's Metsera takeover bid Pfizer has filed a lawsuit to block a rival, higher bid for obesity therapy developer Metsera from Novo Nordisk, claiming it is anti-competitive.
News Novo tries to push Pfizer aside with $9bn bid for Metsera Novo Nordisk has launched an audacious bid to elope with weight-loss therapy developer Metsera, before it can go ahead with a marriage to Pfizer.
News Novo Nordisk's chairman quits amid Foundation row Novo Nordisk's chairman Helge Lund will step down next month under pressure from the group's controlling shareholder, the Novo Nordisk Foundation.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.